DocGo Past Earnings Performance
Past criteria checks 1/6
DocGo has been growing earnings at an average annual rate of 44.9%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 40% per year. DocGo's return on equity is 7.8%, and it has net margins of 3.1%.
Key information
44.9%
Earnings growth rate
176.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 40.0% |
| Return on equity | 7.8% |
| Net Margin | 3.1% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
DocGo: Upside Remains Attractive After Share Price Decline
Mar 20Does DocGo (NASDAQ:DCGO) Have A Healthy Balance Sheet?
Feb 13
DocGo: Good Performance, Trust Issues
Feb 05Why DocGo Inc. (NASDAQ:DCGO) Could Be Worth Watching
Jan 25Fewer Investors Than Expected Jumping On DocGo Inc. (NASDAQ:DCGO)
Jan 04New Forecasts: Here's What Analysts Think The Future Holds For DocGo Inc. (NASDAQ:DCGO)
Nov 08Is Now The Time To Look At Buying DocGo Inc. (NASDAQ:DCGO)?
Jun 07DocGo Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
May 10DocGo Inc.'s (NASDAQ:DCGO) Price In Tune With Earnings
Apr 07DocGo's UK subsidiary Ambulnz Community Partners secures three new contracts
Sep 20DocGo: 'Last Mile' Care More Palatable To The Public Than Telemedicine
Aug 31DocGo's (NASDAQ:DCGO) Earnings Are Of Questionable Quality
Mar 23DocGo: An Undervalued, Potential Disruptor Of Telehealth
Feb 01An Intrinsic Calculation For DocGo Inc. (NASDAQ:DCGO) Suggests It's 20% Undervalued
Jan 25DocGo: Going The Last Mile To Connect Care With Telemedicine
Jan 05Revenue & Expenses Breakdown
How DocGo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 703 | 22 | 164 | 11 |
| 31 Dec 23 | 624 | 7 | 153 | 11 |
| 30 Sep 23 | 534 | 7 | 142 | 9 |
| 30 Jun 23 | 452 | 6 | 127 | 8 |
| 31 Mar 23 | 436 | 20 | 122 | 6 |
| 31 Dec 22 | 441 | 35 | 115 | 5 |
| 30 Sep 22 | 453 | 50 | 110 | 5 |
| 30 Jun 22 | 435 | 50 | 107 | 4 |
| 31 Mar 22 | 387 | 36 | 96 | 4 |
| 31 Dec 21 | 319 | 24 | 84 | 3 |
| 30 Sep 21 | 229 | -4 | 66 | 3 |
| 30 Jun 21 | 170 | -10 | 54 | 2 |
| 31 Mar 21 | 130 | -10 | 45 | 2 |
| 31 Dec 20 | 94 | -14 | 39 | 1 |
| 31 Dec 19 | 48 | -20 | 29 | 1 |
Quality Earnings: DCGO has a high level of non-cash earnings.
Growing Profit Margin: DCGO's current net profit margins (3.1%) are lower than last year (4.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DCGO's earnings have grown significantly by 44.9% per year over the past 5 years.
Accelerating Growth: DCGO's earnings growth over the past year (5.2%) is below its 5-year average (44.9% per year).
Earnings vs Industry: DCGO earnings growth over the past year (5.2%) did not outperform the Healthcare industry 14.9%.
Return on Equity
High ROE: DCGO's Return on Equity (7.8%) is considered low.